Eugene Ozhinsky1, 2, Daniel B. Vigneron1, 3, Susan M. Chang4, Sarah J. Nelson1, 3
1Surbeck Laboratory of Advanced Imaging, Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, United States; 2UC Berkeley - UCSF Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA, United States; 3Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, United States; 4Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, United States
This study evaluated the performance of automatically prescribed 3D MRSI protocol in patients with brain tumors. The data shows robust coverage of the tumor, high consistency of prescription and very good data quality within the T2 lesion. It validates the feasibility of automatically prescribed 3D MRSI in routine brain tumor imaging.
Keywords